欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/6252/001
药品名称Treosulfan Tillomed 5 g Pulver zur Herstellung einer Infusionslösung
活性成分
    • Treosulfan 5.0 g
剂型Powder for solution for injection or infusion
上市许可持有人TILLOMED PHARMA GmbH Mittelstraße 5 / 5 a 12529 Schönefeld Brandenburg Germany
参考成员国 - 产品名称Germany (DE)
互认成员国 - 产品名称
    • France (FR)
    • Spain (ES)
    • Italy (IT)
    • Austria (AT)
    • Czechia (CZ)
      Treosulfan 5g prášek pro infuzní roztok
    • Greece (GR)
    • Poland (PL)
      Treosulfan Zentiva
    • Romania (RO)
    • Denmark (DK)
      Treosulfan Tillomed
    • Finland (FI)
    • Belgium (BE)
      Treosulfan Tillomed 5g Poeder voor oplossing voor infusie
    • Norway (NO)
    • Sweden (SE)
    • Ireland (IE)
    • Netherlands (NL)
    • Portugal (PT)
许可日期2017/12/20
最近更新日期2025/01/07
药物ATC编码
    • L01AB02 treosulfan
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase